Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.10    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.02 (22.222%)
Market Cap: £1.48m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Update on Barb Project

4 Jun 2026 12:30

RNS Number : 0491H
Gunsynd PLC
04 June 2026
 

Gunsynd Plc

("Gunsynd" or the "Company")

Update on Barb Project

 

Gunsynd plc (AIM: GUN) is pleased to provide an update on the Barb Gold Project in Manitoba, Canada, further to the Company's announcement of 14 May 2026.

Critical Discoveries has now finished their initial field work and returned to Winnipeg to pack the samples which are expected to be shipped to the lab shortly.

Critical Discoveries will deliver a fully integrated exploration database for the property, incorporating all new rock sample results, original laboratory certificates and chain-of-custody documentation, formatted for use in QGIS and Excel.

The Company expect the assay results to be available by 30 June 2026 and will provide a further update to the market in due course.

This announcement contains inside information for the purposes of Article 7 of the UK version of the Market Abuse Regulation (EU) 596/2014 (UK MAR). Upon publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

For further information, please contact:

Gunsynd plc

Hamish Harris

+44 (0) 20 3582 6636

Cairn Financial Advisers LLP (Nominated Adviser)

Liam Murray / James Western

+44 20 7213 0880

AlbR Capital Limited (Broker)

Lucy Williams

+44 20 7469 0936

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFFLRTISIIR
Date   Source Headline
17th Jan 20137:00 amRNSContract Wins
10th Jan 201311:01 amRNSForm 8.5 (EPT/NON-RI)
10th Jan 20137:00 amRNSNotice of AGM
4th Jan 20139:00 amRNSForm 8.5 (EPT/NON-RI)
2nd Jan 201312:07 pmRNSForm 8.5 (EPT/NON-RI)
18th Dec 20121:45 pmRNSForm 8.3 - Evocutis PLC
18th Dec 20129:49 amRNSForm 8.3 - Evocutis PLC
17th Dec 20125:08 pmRNSForm 8.3 - Evocutis PLC
17th Dec 20124:43 pmRNSForm 8.3 - Evocutis PLC
17th Dec 201211:52 amRNSForm 8.3 - Evocutis PLC - Amended
17th Dec 201210:55 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 20123:24 pmRNSForm 8 (OPD) Evocutis - Amended
14th Dec 20123:18 pmRNSForm 8.3 - Evocutis PLC
14th Dec 201211:48 amRNSForm 8.3 - Evocutis PLC
14th Dec 201210:14 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 201210:43 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
12th Dec 20127:00 amRNSForm 8.3 - Evocutis PLC
11th Dec 201211:29 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 201210:59 amRNSForm 8.5 (EPT/NON-RI)
7th Dec 201211:12 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.